SOST and kidney disorder: Desjardins et al. revealed that elevated serum sclerostin appears to be associated with cardiovascular mortality in the absence of adjustment for propensity scores including age, phosphate, interleukin-6, renal disease stage, and p-cresyl sulfate [60].